• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995-2007 年丹麦 HIV 患者结核病的发病率、危险因素和死亡率。

Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.

机构信息

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.

出版信息

BMC Pulm Med. 2011 May 23;11:26. doi: 10.1186/1471-2466-11-26.

DOI:10.1186/1471-2466-11-26
PMID:21605366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3115926/
Abstract

BACKGROUND

Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods.

METHODS

We included patients from a population-based, multicenter, nationwide cohort. We calculated incidence rates (IRs) and mortality rates (MRs). Cox's regression analysis was used to estimate risk factors for TB infection with HAART initiation included as time updated variable. Kaplan-Meier was used to estimate mortality after TB.

RESULTS

Among 2,668 patients identified, 120 patients developed TB during the follow-up period. The overall IR was 8.2 cases of TB/1,000 person-years of follow-up (PYR). IRs decreased during the pre-, early and late-HAART periods (37.1/1000 PYR, 12.9/1000 PYR and 6.5/1000 PYR respectively). African and Asian origin, low CD4 cell count and heterosexual and injection drug user route of HIV transmission were risk factors for TB and start of HAART reduced the risk substantially. The overall MR in TB patients was 34.4 deaths per 1,000 PYR (95% Confidence Interval: 22.0-54.0) and was highest in the first two years after the diagnosis of TB.

CONCLUSIONS

Incidence of TB still associated with conventional risk factors as country of birth, low CD4 count and route of HIV infection while HAART reduces the risk substantially. The mortality in this patient population is high in the first two years after TB diagnosis.

摘要

背景

人类免疫缺陷病毒(HIV)感染可导致结核病(TB)。我们描述了在 HIV-1 感染患者中,在预(1995-1996 年)、早(1997-1999 年)和晚(2000-2007 年)高效抗逆转录病毒治疗(HAART)时期,TB 的发病率、危险因素和预后。

方法

我们纳入了来自基于人群的、多中心、全国性队列的患者。我们计算了发病率(IR)和死亡率(MR)。Cox 回归分析用于估计随着 HAART 开始而作为时间更新变量的 TB 感染的危险因素。Kaplan-Meier 用于估计 TB 后的死亡率。

结果

在确定的 2668 名患者中,120 名患者在随访期间发生了 TB。总的 IR 为每 1000 人年随访(PYR)8.2 例 TB。IR 在预、早和晚 HAART 期间下降(分别为 37.1/1000 PYR、12.9/1000 PYR 和 6.5/1000 PYR)。非洲和亚洲血统、低 CD4 细胞计数以及异性恋和注射吸毒者传播 HIV 的途径是 TB 和 HAART 开始的危险因素。TB 患者的总体 MR 为每 1000 PYR 34.4 例死亡(95%置信区间:22.0-54.0),在 TB 诊断后的头两年最高。

结论

TB 的发病率仍与出生国家、低 CD4 计数和 HIV 感染途径等传统危险因素相关,而 HAART 大大降低了风险。在 TB 诊断后的头两年,该患者人群的死亡率很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd0/3115926/0a2863136363/1471-2466-11-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd0/3115926/0a2863136363/1471-2466-11-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fd0/3115926/0a2863136363/1471-2466-11-26-1.jpg

相似文献

1
Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.1995-2007 年丹麦 HIV 患者结核病的发病率、危险因素和死亡率。
BMC Pulm Med. 2011 May 23;11:26. doi: 10.1186/1471-2466-11-26.
2
Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.HIV 阳性患者在布基纳法索启动 HAART 后结核病的发病率。
Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23.
3
Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴的一家三级医院中,接受抗逆转录病毒治疗的大量 HIV 感染患者中结核病的发病率和早期死亡率。
Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.
4
HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.高效抗逆转录病毒疗法与南非感染艾滋病毒儿童的结核病风险:一项多中心回顾性队列研究
Int J Tuberc Lung Dis. 2009 Jul;13(7):862-7.
5
Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.抗反转录病毒治疗(HAART)后 HIV 感染患者的结核病发病率:TST 和 CD4 计数的相互作用。
Int J Tuberc Lung Dis. 2011 Oct;15(10):1347-52. doi: 10.5588/ijtld.10.0686.
6
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?高效抗逆转录病毒治疗(HAART)前后的结核病风险:在低结核发病率环境中,HAART 是否会增加短期结核病风险?
J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):305-10. doi: 10.1097/QAI.0b013e3182182e2d.
7
Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study.结核发病率和病死率在人类免疫缺陷病毒感染者中:丹麦全国队列研究。
Clin Microbiol Infect. 2022 Apr;28(4):570-579. doi: 10.1016/j.cmi.2021.07.036. Epub 2021 Aug 24.
8
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.HAART 前 CD4+ T 淋巴细胞可作为 HIV 感染儿童(合并或不合并结核分枝杆菌感染)HAART 后免疫恢复的生物标志物。
BMC Infect Dis. 2020 Oct 15;20(1):756. doi: 10.1186/s12879-020-05458-w.
9
Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.抗逆转录病毒疗法对结核发病率的影响:巴西的经验,1995-2001 年。
PLoS One. 2007 Sep 5;2(9):e826. doi: 10.1371/journal.pone.0000826.
10
Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.阿比让开始抗逆转录病毒治疗后活动性结核病的危险因素
Am J Respir Crit Care Med. 2005 Jul 1;172(1):123-7. doi: 10.1164/rccm.200410-1342OC. Epub 2005 Apr 1.

引用本文的文献

1
Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.肯尼亚内罗毕肯雅塔国家医院的HIV阳性患者中与HIV相关的机会性感染/病症的类型及流行情况。
Afr Health Sci. 2020 Jun;20(2):615-624. doi: 10.4314/ahs.v20i2.9.
2
Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.博茨瓦纳接受人类免疫缺陷病毒相关结核病治疗的成年人死亡率预测因素:一项回顾性队列研究。
Medicine (Baltimore). 2018 Apr;97(16):e0486. doi: 10.1097/MD.0000000000010486.
3
Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV.

本文引用的文献

1
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.南非感染 HIV 的成年人中异烟肼预防治疗、高效抗逆转录病毒治疗和结核病风险:一项前瞻性队列研究。
AIDS. 2009 Mar 13;23(5):631-6. doi: 10.1097/QAD.0b013e328327964f.
2
Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.来自亚洲艾滋病治疗观察数据库患者中结核病的风险及预后意义。
BMC Infect Dis. 2009 Apr 21;9:46. doi: 10.1186/1471-2334-9-46.
3
Tuberculosis recurrence and its associated risk factors among successfully treated patients.
注射吸毒预测了全国 HIV 感染者队列中活动性结核病的发生。
AIDS. 2017 Nov 13;31(17):2403-2413. doi: 10.1097/QAD.0000000000001635.
4
Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.中国广西HIV/AIDS患者中与结核病(TB)相关的危险因素:一项配对病例对照研究
PLoS One. 2017 Mar 30;12(3):e0173976. doi: 10.1371/journal.pone.0173976. eCollection 2017.
5
Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.欧洲的结核病与艾滋病病毒合并感染:从两个角度审视同一现实。
AIDS. 2016 Nov 28;30(18):2845-2853. doi: 10.1097/QAD.0000000000001252.
6
Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria.尼日利亚结核病/艾滋病病毒合并感染患者的结核病发病率及免疫状况
Ann Thorac Med. 2015 Jul-Sep;10(3):185-92. doi: 10.4103/1817-1737.160838.
7
Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis.接受联合抗逆转录病毒治疗的个体中与艾滋病毒相关的结核病发病率:一项系统评价和荟萃分析。
PLoS One. 2014 Nov 13;9(11):e111209. doi: 10.1371/journal.pone.0111209. eCollection 2014.
8
Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.1983 - 2010年以色列艾滋病毒/艾滋病患者的结核病发病率
PLoS One. 2013 Nov 21;8(11):e79691. doi: 10.1371/journal.pone.0079691. eCollection 2013.
9
Mycobacterium tuberculosis outbreak strain of Danish origin spreading at worrying rates among greenland-born persons in Denmark and Greenland.源自丹麦的结核分枝杆菌暴发菌株正在丹麦和格陵兰岛出生的人群中以令人担忧的速度传播。
J Clin Microbiol. 2013 Dec;51(12):4040-4. doi: 10.1128/JCM.01916-13. Epub 2013 Sep 25.
10
Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso.布基纳法索艾滋病毒/艾滋病患者中结核病感染的风险因素。
AIDS Res Hum Retroviruses. 2013 Jul;29(7):1045-55. doi: 10.1089/aid.2012.0239. Epub 2013 May 9.
结核治愈患者复发及其相关危险因素。
J Epidemiol Community Health. 2009 Oct;63(10):799-804. doi: 10.1136/jech.2008.077560. Epub 2009 Jan 29.
4
Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District.巴西利亚联邦区公共卫生服务机构中感染艾滋病毒/艾滋病患者的结核病发病率及风险因素。
Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):549-55. doi: 10.1590/s0037-86822008000600001.
5
Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy.无掩饰型结核病与结核免疫重建炎症性疾病:抗逆转录病毒治疗开始后的一种疾病谱。
J Infect Dis. 2009 Feb 1;199(3):437-44. doi: 10.1086/595985.
6
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.根据高效抗逆转录病毒治疗(HAART)状态,HIV阳性受试者中结核病的发病率及危险因素。
Int J Tuberc Lung Dis. 2008 Dec;12(12):1393-400.
7
Cohort profile: the Danish HIV cohort study.队列简介:丹麦艾滋病毒队列研究
Int J Epidemiol. 2009 Oct;38(5):1202-6. doi: 10.1093/ije/dyn192. Epub 2008 Sep 17.
8
Survival of persons with and without HIV infection in Denmark, 1995-2005.1995 - 2005年丹麦有和没有感染艾滋病毒者的生存率。
Ann Intern Med. 2007 Jan 16;146(2):87-95. doi: 10.7326/0003-4819-146-2-200701160-00003.
9
Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?预防HIV感染患者的潜伏性结核病:有效且高效,但却效率低下?
Clin Infect Dis. 2007 Jan 1;44(1):103-4. doi: 10.1086/510093. Epub 2006 Nov 28.
10
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.在结核病低传播地区通过结核菌素皮肤试验、预防性治疗和抗逆转录病毒疗法降低结核病发病率。
Clin Infect Dis. 2007 Jan 1;44(1):94-102. doi: 10.1086/510080. Epub 2006 Nov 28.